Difference between revisions of "Talk:Protocols"
(→References to Official Documents) |
(→Spectrometer Calibrations) |
||
| (4 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Introduction== | ==Introduction== | ||
| − | + | The purpose of this page is to collect and share protocols, based on best practices, for a variety of NMR-related activities. | |
| + | |||
==Sample Preparation== | ==Sample Preparation== | ||
# Procedure 1 here | # Procedure 1 here | ||
==Spectrometer Calibrations== | ==Spectrometer Calibrations== | ||
| − | # | + | # Lineshape |
| + | # Sensitivity | ||
| + | # 90<sup>o</sup> Pulse Width | ||
| + | # Decoupling | ||
| + | |||
==Spectrometer Validation== | ==Spectrometer Validation== | ||
# Procedure 1 here | # Procedure 1 here | ||
| Line 13: | Line 18: | ||
==Analytical Method Validation References: Guidance Documents== | ==Analytical Method Validation References: Guidance Documents== | ||
| − | # <1225> Validation of Compendial Procedures. United States | + | # Analytical Procedures and Methods Validation for Drugs and Biologics - Guidance for Industry. US Food and Drug Administration. |
| − | # <761> Nuclear Magnetic Resonance Spectroscopy. United States | + | # <1225> Validation of Compendial Procedures. United States Pharmacopeia |
| + | # <761> Nuclear Magnetic Resonance Spectroscopy. United States Pharmacopeia | ||
# Validation of Analytical Procedures: Text and Methodology Q2(R1). International Conference on Harmonization | # Validation of Analytical Procedures: Text and Methodology Q2(R1). International Conference on Harmonization | ||
# Guide to NMR Method Development and Validation - Part I: Identification and Quantification; EUROLAB Technical Report No. 01/2014. | # Guide to NMR Method Development and Validation - Part I: Identification and Quantification; EUROLAB Technical Report No. 01/2014. | ||
# Guide to NMR Method Development and Validation - Part II: Multivariate Data Analysis; EUROLAB Technical Report No. 01/2015. | # Guide to NMR Method Development and Validation - Part II: Multivariate Data Analysis; EUROLAB Technical Report No. 01/2015. | ||
| + | # Validation of Test Methods - General Principles and Concepts. EUROLAB, 1996. | ||
# JP | # JP | ||
# JIS | # JIS | ||
# ASTM | # ASTM | ||
Latest revision as of 10:46, 27 April 2017
Contents
Introduction
The purpose of this page is to collect and share protocols, based on best practices, for a variety of NMR-related activities.
Sample Preparation
- Procedure 1 here
Spectrometer Calibrations
- Lineshape
- Sensitivity
- 90o Pulse Width
- Decoupling
Spectrometer Validation
- Procedure 1 here
NMR Method Development
- Procedure 1 here
NMR Method Validation
- Procedure 1 here
Analytical Method Validation References: Guidance Documents
- Analytical Procedures and Methods Validation for Drugs and Biologics - Guidance for Industry. US Food and Drug Administration.
- <1225> Validation of Compendial Procedures. United States Pharmacopeia
- <761> Nuclear Magnetic Resonance Spectroscopy. United States Pharmacopeia
- Validation of Analytical Procedures: Text and Methodology Q2(R1). International Conference on Harmonization
- Guide to NMR Method Development and Validation - Part I: Identification and Quantification; EUROLAB Technical Report No. 01/2014.
- Guide to NMR Method Development and Validation - Part II: Multivariate Data Analysis; EUROLAB Technical Report No. 01/2015.
- Validation of Test Methods - General Principles and Concepts. EUROLAB, 1996.
- JP
- JIS
- ASTM
